Alternative Treatments for Premenstrual Dysphoric Disorder

Status Completed

Clinical Trial Summary

The primary aim of this study is to examine the effects of co-administered wake therapy followed by light treatment on mood, and secondarily on circadian rhythms, to test the hypothesis that critically-timed chronotherapy improves mood by correcting phase disturbances in melatonin and sleep in women with Premenstrual Dysphoric Disorder.

Clinical Trial Description

The design is a randomized cross-over contrasting Late Wake Therapy plus morning bright light (LWT+Am BWL)vs. Early Wake Therapy plus evening bright light (EWT+PM BWL)administered in the luteal phase of two separate menstrual cycles, and preceded by 2 evaluation months. To lessen the patient's burden, the 1-night EWT or LWT and the following 7-day BWL interventions will be conducted at home, given at a fixed point in each menstrual cycle, from day 1 to 7 after the mid-cycle luteinizing hormone(LH) surge (ovulation). We anticipate that LWT+7 days of AM BWL (vs. EWT+PM BWL) will produce much greater mood benefits and larger physiological responses, than the one-time light pulses used in our earlier phase-shift studies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01799733
Study type	Interventional
Source	University of California, San Diego
Contact
Status	Completed
Phase	N/A
Start date	June 18, 2013
Completion date	July 3, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03862469` - Premenstrual Hormonal and Affective State Evaluation (PHASE) Project	N/A
Active, not recruiting	`NCT00536198` - Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder	N/A
Completed	`NCT03449979` - Single Session of tACS in a Depressive Episode	N/A
Completed	`NCT00516113` - A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria	Phase 4
Recruiting	`NCT05098574` - Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder	Phase 2
Withdrawn	`NCT04123483` - EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders	Phase 4
Completed	`NCT00518570` - Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)	N/A
Not yet recruiting	`NCT01217775` - Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder	Phase 3
Terminated	`NCT02362191` - Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD	N/A
Completed	`NCT00678574` - The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder	Phase 4
Active, not recruiting	`NCT05327075` - Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females
Not yet recruiting	`NCT02448836` - Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD)	N/A
Completed	`NCT06227676` - Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25	Phase 2/Phase 3
Active, not recruiting	`NCT02508103` - Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study	Phase 2/Phase 3
Completed	`NCT00927095` - Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)	Phase 4
Completed	`NCT00089414` - Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives	Phase 2
Not yet recruiting	`NCT06462391` - Adapting and Piloting Acceptance and Commitment Therapy (ACT) for Severe Premenstrual Mood Symptoms	N/A
Completed	`NCT01875718` - A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)	Phase 1/Phase 2
Completed	`NCT06136104` - The Effects of Mixhers HERTIME Supplements on Menstrual Symptoms	N/A
Completed	`NCT01385709` - The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels	N/A